Skip to main content
Clinical Trials/NCT06121921
NCT06121921CompletedNot Applicable

A Pilot Study Assessing the Feasibility and Effectiveness of a Perioperative Multi-component Intervention in Patients With Acute Decompensated Aortic Stenosis Undergoing Urgent Transcatheter Aortic Valve Intervention

Barts & The London NHS Trust2 sites in 1 country40 target enrollmentStarted: June 7, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
2
Primary Endpoint
Feasibility: Safety

Study Overview

Brief Summary

This is a pilot randomised control study assessing the feasibility and effectiveness of a perioperative multi-component intervention aimed at reducing adverse hospital events and improving functional outcomes in patients with acute decompensated aortic stenosis undergoing urgent transcatheter aortic valve implantation compared to standard care.

The intervention will consist of physical rehabilitation, delirium prevention, nutritional supplementation and anaemia correction (where indicated). The primary objective is to determine the feasibility and safety of delivering this intervention Secondary objectives include investigating the impact on adverse hospital events such as hospital-acquired disability and post-TAVI delirium, and on health-related quality of life and functional recovery following TAVI.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
70 Years to — (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age > 70 years
  • Ability to provide written informed consent
  • Ability to speak English
  • Exclusion criteria:
  • Clinical instability defined as requiring use of inotropes/mechanical-circulatory support during admission or post-cardiac arrest
  • Active delirium (4AT score ≥ 4) at time of recruitment
  • Parkinson's disease (Hoehn & Yahr stage 3-5)
  • Recent stroke (within 7 days preceding recruitment)
  • Terminal condition (e.g. metastatic cancer) with life expectancy < 12 months
  • Clinical unsuitable for recruitment to trial according to the discretion of the research team

Exclusion Criteria

  • Not provided

Arms & Interventions

Control

No Intervention

Routine inpatient care

Intervention

Experimental

Perioperative multi-component intervention

Intervention: Perioperative multi-component intervention (Other)

Outcomes

Primary Outcomes

Feasibility: Safety

Time Frame: On discharge: e.g. 2-7 days

In-hospital adverse events (e.g. falls, ischaemia, arrhythmia, acute kidney injury), in-hospital mortality

Feasibility: Recruitment rates

Time Frame: 1 year

Average number of patients per month willing to give informed consent and be randomised into a trial of a perioperative frailty intervention

Secondary Outcomes

  • Change in cognitive function(30 days)
  • Incidence of hospital-acquired disability(30 days)
  • Incidence of delirium(Daily (during inpatient admission) until the seventh day post-TAVI and then twice weekly thereafter)
  • Changes in health-related quality of life(30 days)
  • Change in mood(30 days)
  • Incidence of falls during hospitalisation(On discharge: e.g. 2-7 days)
  • Length of hospital stay(On discharge: e.g. 2-7 days)
  • Discharge destination(On discharge: e.g. 2-7 days)
  • Unplanned readmissions(30 days)
  • Mortality(30 days)
  • Changes in physical frailty(On discharge: e.g. 2-7 days)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials